Richard S. Lindahl - 15 Nov 2021 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Chief Financial Officer
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
15 Nov 2021
Net transactions value
+$112,380
Form type
4
Filing time
15 Nov 2021, 16:53:15 UTC
Previous filing
11 May 2021
Next filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Purchase $112,380 +3,000 +8.1% $37.46* 39,919 15 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $37.32 to $37.63.